| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| APLS | Apellis Pharmaceuticals, Inc. | Sullivan Timothy Eugene | Chief Financial Officer | Apr 01, 2024 | Sale | $34.34 | 8,000 | 274,760 | 97,338 | Apr 02, 2024, 04:06 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Sullivan Timothy Eugene | Chief Financial Officer | Mar 01, 2024 | Sale | $36.63 | 12,000 | 439,520 | 99,338 | Mar 05, 2024, 04:04 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Sullivan Timothy Eugene | Chief Financial Officer | Feb 12, 2024 | Sale | $67.77 | 1,431 | 96,974 | 93,338 | Feb 13, 2024, 04:59 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Sullivan Timothy Eugene | Chief Financial Officer | Jan 29, 2024 | Sale | $64.14 | 906 | 58,109 | 94,769 | Jan 31, 2024, 04:34 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Sullivan Timothy Eugene | Chief Financial Officer | Jan 22, 2024 | Sale | $65.00 | 3,551 | 230,801 | 95,675 | Jan 23, 2024, 06:13 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Sullivan Timothy Eugene | Chief Financial Officer | Jan 16, 2024 | Sale | $66.81 | 2,235 | 149,317 | 99,226 | Jan 17, 2024, 04:36 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Sullivan Timothy Eugene | Chief Financial Officer | Nov 30, 2023 | Option Exercise | $32.38 | 28,316 | 916,889 | 91,871 | Dec 01, 2023, 04:11 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Sullivan Timothy Eugene | Chief Financial Officer | Jul 03, 2023 | Sale | $50.00 | 13,558 | 677,921 | 84,492 | Jul 06, 2023, 04:16 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Sullivan Timothy Eugene | Chief Financial Officer | Jun 05, 2023 | Sale | $49.42 | 139,558 | 6,896,410 | 147,492 | Jun 06, 2023, 04:59 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Sullivan Timothy Eugene | Chief Financial Officer | Feb 21, 2023 | Option Exercise | $58.50 | 974 | 56,979 | 133,945 | Feb 22, 2023, 06:42 AM | |
| APLS | Apellis Pharmaceuticals, Inc. | Sullivan Timothy Eugene | Chief Financial Officer | Feb 10, 2023 | Option Exercise | $51.21 | 975 | 49,930 | 123,236 | Feb 14, 2023, 04:59 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Sullivan Timothy Eugene | Chief Financial Officer | Jan 27, 2023 | Option Exercise | $52.77 | 551 | 29,076 | 124,211 | Jan 30, 2023, 05:05 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Sullivan Timothy Eugene | Chief Financial Officer | Jan 20, 2023 | Option Exercise | $52.05 | 2,379 | 123,827 | 124,762 | Jan 24, 2023, 05:23 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Sullivan Timothy Eugene | Chief Financial Officer | Jan 28, 2022 | Option Exercise | $38.59 | 650 | 25,084 | 104,278 | Feb 01, 2022, 06:05 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Sullivan Timothy Eugene | Chief Financial Officer | Feb 10, 2021 | Option Exercise | $47.72 | 858 | 40,944 | 34,261 | Feb 11, 2021, 04:16 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Sullivan Timothy Eugene | Chief Financial Officer | Aug 29, 2019 | Buy | $29.71 | 11,699 | 347,630 | 11,699 | Sep 03, 2019, 04:13 PM |
Menu